CA Patent

CA2128722A1 — Novel protein tyrosine kinases

Assigned to Genentech Inc · Expires 1993-08-05 · 33y expired

What this patent protects

2128722 9315201 PCTABS00024 The identification and isolation of novel protein tyrosine kinase genes present on human megakaryocytic and lymphocytic cells, the proteins encoded by these genes, antibodies specific for the encoded proteins, RNA nucleic acid sequences which hybridize…

USPTO Abstract

2128722 9315201 PCTABS00024 The identification and isolation of novel protein tyrosine kinase genes present on human megakaryocytic and lymphocytic cells, the proteins encoded by these genes, antibodies specific for the encoded proteins, RNA nucleic acid sequences which hybridize to the genes and methods of use therefor.

Drugs covered by this patent

Patent Metadata

Patent number
CA2128722A1
Jurisdiction
CA
Classification
—
Expires
1993-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.